230 related articles for article (PubMed ID: 8913728)
1. Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localisation of the critical interval to 30 kb.
Bell SM; Zuo J; Myers RM; Knowles MA
Genes Chromosomes Cancer; 1996 Oct; 17(2):108-17. PubMed ID: 8913728
[TBL] [Abstract][Full Text] [Related]
2. Deletion of two regions on chromosome 4 in bladder carcinoma: definition of a critical 750kB region at 4p16.3.
Elder PA; Bell SM; Knowles MA
Oncogene; 1994 Dec; 9(12):3433-6. PubMed ID: 7970702
[TBL] [Abstract][Full Text] [Related]
3. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer.
Srivatsan ES; Chakrabarti R; Zainabadi K; Pack SD; Benyamini P; Mendonca MS; Yang PK; Kang K; Motamedi D; Sawicki MP; Zhuang Z; Jesudasan RA; Bengtsson U; Sun C; Roe BA; Stanbridge EJ; Wilczynski SP; Redpath JL
Oncogene; 2002 Aug; 21(36):5631-42. PubMed ID: 12165862
[TBL] [Abstract][Full Text] [Related]
4. Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer.
Takle LA; Knowles MA
Oncogene; 1996 Mar; 12(5):1083-7. PubMed ID: 8649800
[TBL] [Abstract][Full Text] [Related]
5. Defining a common region of deletion at 13q21 in human cancers.
Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
[TBL] [Abstract][Full Text] [Related]
6. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease.
Yoon DS; Li L; Zhang RD; Kram A; Ro JY; Johnston D; Grossman HB; Scherer S; Czerniak B
Oncogene; 2001 Aug; 20(36):5005-14. PubMed ID: 11526485
[TBL] [Abstract][Full Text] [Related]
7. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss.
Adams J; Williams SV; Aveyard JS; Knowles MA
Cancer Res; 2005 Jan; 65(1):66-75. PubMed ID: 15665280
[TBL] [Abstract][Full Text] [Related]
9. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.
van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC
Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858
[TBL] [Abstract][Full Text] [Related]
10. A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D.
Paige AJ; Taylor KJ; Stewart A; Sgouros JG; Gabra H; Sellar GC; Smyth JF; Porteous DJ; Watson JE
Cancer Res; 2000 Mar; 60(6):1690-7. PubMed ID: 10749141
[TBL] [Abstract][Full Text] [Related]
11. Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci.
Habuchi T; Devlin J; Elder PA; Knowles MA
Oncogene; 1995 Oct; 11(8):1671-4. PubMed ID: 7478593
[TBL] [Abstract][Full Text] [Related]
12. Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder.
Cappellen D; Gil Diez de Medina S; Chopin D; Thiery JP; Radvanyi F
Oncogene; 1997 Jun; 14(25):3059-66. PubMed ID: 9223669
[TBL] [Abstract][Full Text] [Related]
13. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
14. A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p).
Baens M; Wlodarska I; Corveleyn A; Hoornaert I; Hagemeijer A; Marynen P
Genomics; 1999 Feb; 56(1):40-50. PubMed ID: 10036184
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer.
Bell SM; Shaw M; Jou YS; Myers RM; Knowles MA
Genomics; 1997 Sep; 44(2):163-70. PubMed ID: 9299232
[TBL] [Abstract][Full Text] [Related]
16. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer.
Nishiyama H; Takahashi T; Kakehi Y; Habuchi T; Knowles MA
Genes Chromosomes Cancer; 1999 Oct; 26(2):171-5. PubMed ID: 10469456
[TBL] [Abstract][Full Text] [Related]
17. Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer.
Stadler WM; Sherman J; Bohlander SK; Roulston D; Dreyling M; Rukstalis D; Olopade OI
Cancer Res; 1994 Apr; 54(8):2060-3. PubMed ID: 7513608
[TBL] [Abstract][Full Text] [Related]
18. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.
Mendonca MS; Farrington DL; Mayhugh BM; Qin Y; Temples T; Comerford K; Chakrabarti R; Zainabadi K; Redpath JL; Stanbridge EJ; Srivatsan ES
Genes Chromosomes Cancer; 2004 Apr; 39(4):277-87. PubMed ID: 14978789
[TBL] [Abstract][Full Text] [Related]
19. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.
Knowles MA; Shaw ME; Proctor AJ
Oncogene; 1993 May; 8(5):1357-64. PubMed ID: 8097582
[TBL] [Abstract][Full Text] [Related]
20. Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer.
Kagan J; Liu J; Stein JD; Wagner SS; Babkowski R; Grossman BH; Katz RL
Oncogene; 1998 Feb; 16(7):909-13. PubMed ID: 9484782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
